
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Antibody Inhibits the Development of Experimental Skin Tumors
Cancer Research UK Translational Oncology Laboratory, John Vane Science Centre, Barts & The London, Queen Marys School of Medicine and Dentistry, London EC1M 6BQ, United Kingdom [K. A. S., R. J. M., C. H. A., N. E., R. G. T., F. R. B.], and Centocor, Malvern, Pennsylvania 19355 [B. J. S., D. J. S.]
2 To whom requests for reprints should be addressed, at Cancer Research UK Translational Oncology Laboratory, Barts & The London, Queen Marys School of Medicine and Dentistry, 3rd Floor, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, United Kingdom. Phone: 44-207-882-5797; Fax: 44-207-882-6110; E-mail: kate.scott{at}cancer.org.uk
The proinflammatory cytokine tumor necrosis factor-
(TNF-
) was originally considered to have activity against malignant disease. However, recent studies suggest TNF-
may also act as an endogenous tumor promoter. In the present work, mice deficient in TNF-
either genetically (TNF-
-/-) or after blockade with a neutralizing antibody (cV1q) were used to investigate the role of TNF-
in skin tumor development. Papillomas were induced in wild-type (wt) mice after treatment of skin with the initiating agent 9,10-dimethyl-1,2-benzanthracene followed by promotion with 12-O-tetradecanoylphorbol-13-acetate (TPA) for 15 weeks. TNF-
-/- mice were resistant to papilloma development when compared with wt mice on C57Bl/6J, 129/SvEv, and BALB/c genetic backgrounds. Primary murine keratinocytes (newborn keratinocytes) and skin homogenates were used to characterize TPA-stimulated TNF-
expression. TPA induced TNF-
protein in newborn keratinocytes in vitro and epidermis in vivo. Neutralization of TNF-
protein with cV1q in vivo for 015 weeks of promotion significantly decreased skin tumor development after 9,10-dimethyl-1,2-benzanthracene/TPA treatment. cV1q treatment during the early stages of tumor promotion (06 weeks) was equally effective. These data suggest that early induction of TNF-
is critical for skin tumor promotion. cV1q also reduced TPA-stimulated expression of matrix metalloproteinase 9 and granulocyte macrophage colony-stimulating factor, proteins that are differentially regulated in wt and TNF-
-/- epidermis. Treatment of the 410.4 transplantable breast carcinoma with cV1q reduced tumor growth in vivo, illustrating that inhibition of tumor growth through neutralization of TNF-
is not limited to skin carcinogenesis. These results provide further evidence for procancer actions of TNF-
and give some rationale for use of TNF-
antagonists in cancer prevention and treatment.
This article has been cited by other articles:
![]() |
Y.-S. Lee, K.-H. Lim, X. Guo, Y. Kawaguchi, Y. Gao, T. Barrientos, P. Ordentlich, X.-F. Wang, C. M. Counter, and T.-P. Yao The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis Cancer Res., September 15, 2008; 68(18): 7561 - 7569. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tonnetti, S. Netzel-Arnett, G. A. Darnell, T. Hayes, M. S. Buzza, I. E. Anglin, A. Suhrbier, and T. M. Antalis SerpinB2 Protection of Retinoblastoma Protein from Calpain Enhances Tumor Cell Survival Cancer Res., July 15, 2008; 68(14): 5648 - 5657. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ouyang, Y. Hu, J. Li, M. Ding, Y. Lu, D. Zhang, Y. Yan, L. Song, Q. Qu, D. Desai, et al. Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells Carcinogenesis, October 1, 2007; 28(10): 2218 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ding, X. Zhang, J. Li, L. Song, W. Ouyang, D. Zhang, C. Xue, M. Costa, J. A. Melendez, and C. Huang Nickel Compounds Render Anti-apoptotic Effect to Human Bronchial Epithelial Beas-2B Cells by Induction of Cyclooxygenase-2 through an IKKbeta/p65-dependent and IKK{alpha}- and p50-independent Pathway J. Biol. Chem., December 22, 2006; 281(51): 39022 - 39032. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yan, H. Wang, Z. N. Rabbani, Y. Zhao, W. Li, Y. Yuan, F. Li, M. W. Dewhirst, and C.-Y. Li Tumor Necrosis Factor-{alpha} Is a Potent Endogenous Mutagen that Promotes Cellular Transformation Cancer Res., December 15, 2006; 66(24): 11565 - 11570. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, X. Cheng, M. Merched-Sauvage, C. Caulin, D. R. Roop, and P. J. Koch An unexpected role for keratin 10 end domains in susceptibility to skin cancer J. Cell Sci., December 15, 2006; 119(24): 5067 - 5076. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Devoogdt, H. Revets, A. Kindt, Y. Q. Liu, P. De Baetselier, and G. H. Ghassabeh The Tumor-Promoting Effect of TNF-{alpha} Involves the Induction of Secretory Leukocyte Protease Inhibitor J. Immunol., December 1, 2006; 177(11): 8046 - 8052. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ding, J. Li, C. Xue, K. Wu, W. Ouyang, D. Zhang, Y. Yan, and C. Huang Cyclooxygenase-2 Induction by Arsenite Is through a Nuclear Factor of Activated T-cell-dependent Pathway and Plays an Antiapoptotic Role in Beas-2B Cells J. Biol. Chem., August 25, 2006; 281(34): 24405 - 24413. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yan, J. Li, W. Ouyang, Q. Ma, Y. Hu, D. Zhang, J. Ding, Q. Qu, K. Subbaramaiah, and C. Huang NFAT3 is specifically required for TNF-{alpha}-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells J. Cell Sci., July 15, 2006; 119(14): 2985 - 2994. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hagemann, J. Wilson, F. Burke, H. Kulbe, N. F. Li, A. Pluddemann, K. Charles, S. Gordon, and F. R. Balkwill Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol., April 15, 2006; 176(8): 5023 - 5032. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Szlosarek, M. J. Grimshaw, H. Kulbe, J. L. Wilson, G. D. Wilbanks, F. Burke, and F. R. Balkwill Expression and regulation of tumor necrosis factor {alpha} in normal and malignant ovarian epithelium. Mol. Cancer Ther., February 1, 2006; 5(2): 382 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Tachado, J. Zhang, J. Zhu, N. Patel, and H. Koziel HIV Impairs TNF-{alpha} Release in Response to Toll-Like Receptor 4 Stimulation in Human Macrophages In Vitro Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 610 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Montesano, P. Soulie, J. A. Eble, and F. Carrozzino Tumour necrosis factor {alpha} confers an invasive, transformed phenotype on mammary epithelial cells J. Cell Sci., August 1, 2005; 118(15): 3487 - 3500. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shan, Y. Zhuo, D. Chin, C. A. Morris, G. F. Morris, and J. A. Lasky Cyclin-dependent Kinase 9 Is Required for Tumor Necrosis Factor-{alpha}-stimulated Matrix Metalloproteinase-9 Expression in Human Lung Adenocarcinoma Cells J. Biol. Chem., January 14, 2005; 280(2): 1103 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Peterson, S. Hughes, D. E. Dimcheff, K. Wehrly, and B. Chesebro Separate Sequences in a Murine Retroviral Envelope Protein Mediate Neuropathogenesis by Complementary Mechanisms with Differing Requirements for Tumor Necrosis Factor Alpha J. Virol., December 1, 2004; 78(23): 13104 - 13112. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Nicol, M. Yoon, J. M. Ward, M. Yamashita, K. Fukamachi, J. M. Peters, and F. J. Gonzalez PPAR{gamma} influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis Carcinogenesis, September 1, 2004; 25(9): 1747 - 1755. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |